Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Kaye

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Virology|February 1, 1995
The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residuesK M Kaye, K M Izumi, G Mosialos, et al.
Viral Immunology|January 17, 2002
The Kaposi' s sarcoma-associated herpesvirus latency-associated nuclear antigenT Komatsu, A J Barbera, M E Ballestas, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1982
Cefazolin versus cephalothin in beta-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental modelJ Carrizosa, W D Kobasa, R Snepar, et al.
Journal of Virology|July 1, 1986
Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 (Dearing)K M Kaye, D R Spriggs, R Bassel-Duby, et al.
Journal of Virology|November 13, 1999
An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformationK M Kaye, K M Izumi, H Li, et al.
Molecular and Cellular Biology|December 1, 1996
Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activationO Devergne, E Hatzivassiliou, K M Izumi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1996
Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming proteinK M Kaye, O Devergne, J N Harada, et al.
Oncogene|June 19, 1997
Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factorsA G Eliopoulos, M Stack, C W Dawson, et al.
The New England Journal of Medicine|August 13, 1998
Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipientD Jones, M E Ballestas, K M Kaye, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Virology|February 1, 1995
The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residuesK M Kaye, K M Izumi, G Mosialos, et al.
Viral Immunology|January 17, 2002
The Kaposi' s sarcoma-associated herpesvirus latency-associated nuclear antigenT Komatsu, A J Barbera, M E Ballestas, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1982
Cefazolin versus cephalothin in beta-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental modelJ Carrizosa, W D Kobasa, R Snepar, et al.
Journal of Virology|July 1, 1986
Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 (Dearing)K M Kaye, D R Spriggs, R Bassel-Duby, et al.
Journal of Virology|November 13, 1999
An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformationK M Kaye, K M Izumi, H Li, et al.
Molecular and Cellular Biology|December 1, 1996
Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activationO Devergne, E Hatzivassiliou, K M Izumi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1996
Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming proteinK M Kaye, O Devergne, J N Harada, et al.
Oncogene|June 19, 1997
Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factorsA G Eliopoulos, M Stack, C W Dawson, et al.
The New England Journal of Medicine|August 13, 1998
Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipientD Jones, M E Ballestas, K M Kaye, et al.
Pageof 2